Stepan CO Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NYSE
SCL
Stepan CORuben Dario Velasquez, SVP & Chief Financial Officer of Stepan Co, reported multiple transactions in common stock on August 10, 2026.
NYSE
SCL
Stepan CORobin J. Weitkamp, VP and GM of Surfactants-INT at Stepan Co, reported the vesting of 90 restricted stock units and a subsequent sale of 50 shares to cover tax obligations.
NYSE
SCL
Stepan COStepan Company executive Shawn G. Lisle filed an amendment to correct the exercise price of stock appreciation rights reported in a previous SEC filing.
NYSE
SCL
Stepan COStepan Company executive Andrea J. Barry filed an amendment to correct the exercise price of stock appreciation rights.
NYSE
SCL
Stepan COSean T. Moriarty, VP & GM of Surfactants at Stepan Co., filed an amendment to correct the exercise price of previously reported stock appreciation rights.
NYSE
SCL
Stepan COStepan Company executive Richard Finn Stepan filed an amendment to correct an administrative error regarding the exercise price of stock appreciation rights.
NYSE
SCL
Stepan COStepan Company CFO Ruben Dario Velasquez filed an amendment to correct an administrative error regarding the exercise price of stock appreciation rights.
NYSE
SCL
Stepan COStepan Company EVP Robert Haire filed an amendment to correct an administrative error regarding the exercise price of stock appreciation rights.
NYSE
SCL
Stepan COStepan Company CEO Luis Rojo filed an amendment to correct an administrative error regarding the exercise price of stock appreciation rights.
NYSE
SCL
Stepan COStepan Company Director Corning F. Painter acquired 2,566 shares of common stock at a price of $52.61 per share.
NYSE
SCL
Stepan CODirector F. Quinn Stepan Jr. acquired 2,566 shares of Stepan Company common stock at a price of $52.61 per share.
NYSE
SCL
Stepan CODirector Jan Stern Reed acquired 2,566 shares of Stepan Company common stock at a price of $52.61 per share.
NYSE
SCL
Stepan COStepan Company director Susan Lewis acquired 2,566 shares of common stock in a transaction dated May 8, 2026.
NYSE
SCL
Stepan COStepan Company Director Joaquin Delgado acquired 2,566 shares of common stock at a price of $52.61 per share.
NYSE
SCL
Stepan COStepan Company director Lorinda Burgess acquired 2,566 shares of common stock, increasing her total beneficial ownership to 5,900 shares.
NYSE
SCL
Stepan CODirector Randall S. Dearth acquired 2,566 shares of Stepan Co common stock at a price of $52.61 per share.
NYSE
SCL
Stepan CORobert Haire, EVP of Supply Chain at Stepan Co, reported transactions involving restricted stock units and common stock.
NYSE
SCL
Stepan COStepan Company executive Robin J. Weitkamp was granted restricted stock units, stock appreciation rights, and performance shares as part of an equity compensation package.
NYSE
SCL
Stepan COStepan Company VP and GM of Surfactants NA, Adriano Jose Galimberti Afonso, was granted performance shares, restricted stock units, and stock appreciation rights.
NYSE
SCL
Stepan COStepan Company's VP and General Manager of Polymers, Richard Stepan, acquired common stock through the vesting of Restricted Stock Units, partially offset by tax withholdings.
NYSE
SCL
Stepan COStepan Co. President and CEO Luis Rojo reported the exercise of restricted stock units and subsequent tax-related share dispositions.
NYSE
SCL
Stepan COStepan Company's EVP of Supply Chain, Robert Joseph Haire, settled restricted stock units and adjusted his beneficial ownership through tax withholdings in early March 2026.
NYSE
SCL
Stepan COStepan Co. VP & GM Surfactants, Sean T. Moriarty, reported the conversion of restricted stock units into common stock and related tax withholdings.
NYSE
SCL
Stepan COStepan Co.'s VP & GM of Surfactants, Sean T. Moriarty, filed an amended Form 4 to correct previously reported Stock Appreciation Right amounts and disclose recent equity transactions.
NYSE
SCL
Stepan COStepan Company's VP, General Counsel & Secretary, Shawn G. Lisle, reported the acquisition of common stock, restricted stock units, performance shares, and stock appreciation rights.
NYSE
SCL
Stepan COAndrea Jean Barry, Stepan Company's VP & CHRO, reported acquiring common stock and various equity awards, including RSUs, performance shares, and stock appreciation rights.
NYSE
SCL
Stepan COStepan Company's EVP of Supply Chain, Robert Haire, reported significant acquisitions of common stock, restricted stock units, performance shares, and stock appreciation rights.
NYSE
SCL
Stepan COStepan Co.'s VP & GM of Surfactants, Sean Thomas Moriarty, increased his beneficial ownership through stock acquisition and significant equity grants.
NYSE
SCL
Stepan COStepan Company's VP and General Manager of Polymers, Richard Finn Stepan, reported the acquisition of common stock and various equity awards, including SARs, performance shares, and RSUs.
NYSE
SCL
Stepan COStepan Company's VP and Chief Financial Officer, Ruben Dario Velasquez, reported the acquisition of common stock, restricted stock units, performance shares, and stock appreciation rights.